[1] NARAYAN RR, CREASY JM, GOLDMAN DA, et al. Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations[J]. Cancer, 2019, 125(4): 575. doi: 10.1002/cncr.31850
[2] SUN LJ, GUAN A, XU WY, et al. γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma[J]. World J Gastrointest Oncol, 2020, 12(9): 1014. doi: 10.4251/wjgo.v12.i9.1014
[3] CHA SY, KIM YK, MIN JH, et al. Usefulness of noncontrast MRI in differentiation between gallbladder carcinoma and benign conditions manifesting as focal mild wall thickening[J]. Clin Imaging, 2019, 54(2): 63.
[4] DELAVERIS CS, WEBSTER ER, BANIK SM, et al. Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus[J]. Proc Natl Acad Sci U S A, 2020, 117(23): 12643. doi: 10.1073/pnas.1921962117
[5] PINZON MARTIN SANDRA, SEEBERGER PETER H, VARONarón Silva Daniel, Mucins and Pathogenic Mucin-Like Molecules Are Immunomodulators During Infection and Targets for Diagnostics and Vaccines[J]. Front Chem, 2019, 7(8): 710.
[6] CRAWFORD A, HABER L, VAZZANA K, et al. Abstract 1777: REGN4018, a novel MUC16xCD3 bispecific T-cell engager for the treatment of ovarian cancer[J]. Cancer Res, 2018, 78(13 Supplement): 1777.
[7] ZHAO HJ, ZHANG L. MUC16 mutation predicts a favorable clinical outcome and correlates decreased Warburg effect in gastric cancer[J]. Biochem Biophys Res Commun, 2018, 506(4): 780. doi: 10.1016/j.bbrc.2018.10.156
[8] ZHANG FB, ZHANG AM, ZHANG ZB, et al. Preoperative differential diagnosis between intrahepatic biliary cystadenoma and cystadenocarcinoma: a single-center experience[J]. World J Gastroenterol, 2014, 20(35): 12595. doi: 10.3748/wjg.v20.i35.12595
[9] HIGASHI M, YAMADA N, YOKOYAMA S, et al. Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type[J]. Pathobiology, 2012, 79(2): 101. doi: 10.1159/000335164
[10] 段海章, 李凡, 孙岩. 黏蛋白在胆管癌中的研究进展[J]. 现代肿瘤医学, 2015, 23(22): 3357.
[11] 段海章, 陈进忠, 石岩, 等. MUC1和MUC16在胆囊癌中的表达及临床意义[J]. 现代肿瘤医学, 2018, 26(18): 77.
[12] FAN K, WANG JW, SUN WT, et al. MUC16 C-terminal binding with ALDOC disrupts the ability of ALDOC to sense glucose and promotes gallbladder carcinoma growth[J]. Exp Cell Res, 2020, 394(1): 112118. doi: 10.1016/j.yexcr.2020.112118
[13] 刘畅, 张珉, 田兴. MUC16对胆囊癌细胞生物学行为的调控作用及机制分析[J]. 肿瘤学杂志, 2019, 25(5): 436.
[14] LU EM, RATNAYAKE J, RICH AM. Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma[J]. BMC Oral Health, 2019, 19(1): 233. doi: 10.1186/s12903-019-0928-9
[15] 王阳, 胡跃世, 李征, 等. miR-124在膀胱癌中的表达及其临床意义[J]. 第三军医大学学报, 2020, 42(10): 78.
[16] HARA K, UCHIDA M, TAGATA R, et al. Structure of proliferating cell nuclear antigen (PCNA) bound to an APIM peptide reveals the universality of PCNA interaction[J]. Acta Crystallogr F Struct Biol Commun, 2018, 74(Pt 4): 214.
[17] SPEISER P, WANNER C, TEMPFER C, et al. CD44 is an independent prognostic factor in early-stage cervical cancer. [J]. Int J Cancer, 2015, 74(2): 185.
[18] ZHOU F, ZHANG YH, SUN JH, et al. Characteristics of a novel cell line ZJU-0430 established from human gallbladder carcinoma[J]. Cancer Cell Int, 2019, 19(5): 190.